Article Details
Retrieved on: 2023-10-23 19:29:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The deal also includes the option for Roche to join with Pfizer on another antibody therapy. London-based biotech firm Roivant Sciences (ROIV) agreed ...
Article found on: www.investopedia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here